Nanotransfer

Nanotransfer is revolutionazing gene therapy, by addressing diseases at their molecular roots. One of the major challenges in this promising area has been the effective delivery of functional genes into damaged cells. Nanotransfer is overcoming this hurdle by developing optimal vehicles for gene therapies, ensuring these transformative treatments can reach all patients. Democratizing access to next-generation therapies, offering hope for lasting cures will significantly improve quality of life for those affected by genetic conditions.
Year
2024
Industry
Health Tech
Stage
Early
  • CTO
    Carla Giacomelli
  • COO
    Julia Mattoni